- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Strong Balance Sheet Stocks
U.K. Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
40
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
40 companies
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-82.0%
ImmuPharma
Market Cap: UK£52.7m
A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.
IMM
UK£0.10
7D
-13.8%
1Y
470.8%
Hemogenyx Pharmaceuticals
Market Cap: UK£67.8m
A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.
HEMO
UK£12.65
7D
-18.1%
1Y
79.2%
Avacta Group
Market Cap: UK£207.9m
Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.
AVCT
UK£0.54
7D
-0.5%
1Y
8.1%